Diltiazem: 20 Years' Experience in Cardiovascular Medicine

Clinical Cardiology

Volumn 26, Issue 11 SUPPL., 2003, Pages

  Fagan, Timothy C ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Camp Lowell   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL T TYPE; CARDIZEM LA; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; NIFEDIPINE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; EXTENDED RELEASE FORMULATION; HEADACHE; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; HYPOTENSION; REFLEX TACHYCARDIA; TACHYCARDIA;

EID: 0242268085     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960261602     Document Type: Article

References (29)

1. Conlin PR, Williams GH: Use of calcium channel blockers in hypertension. Adv Intern Med 1998;43:533-562
2. Robertson RM, Robertson D: Drugs used for the treatment of myocardial ischemia. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (Eds. Hardman JG, Limbird LE), p. 759-779. New York: McGraw-Hill, 1996
3. Palma-Gamiz JL: High blood pressure and calcium antagonism. Cardiology 1997;88(suppl 1):39-46
4. CARDIZEM® CD Prescribing Information. July 2000. Aventis Pharmaceuticals, Kansas City, MO 64137
5. Buckley MM, Grant SM, Goa KL, McTavish D, Sorkin EM: Diltiazem: A reappraisal of its pharmacological properties and therapeutic use. Drugs 1990;39:757-806
6. Pool PE: Anomalies in the dosing of diltiazem. Clin Cardiol 2000; 23:18-23
7. Dupont AG, Coupez JM, Jensen P, Coupez-Lopinot R, Schoors DF, Hermanns P, Nicolas M: Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension. Cardiovasc Drugs Ther 1991;5:701-707
8. Massie BM, Der E, Herman TS, Topolski P, Park G, Stewart WH: 24-hour efficacy of once-daily diltiazem in essential hypertension. Clin Cardiol 1992;15:365-368
9. Woehler TR, Eff J, Graney W, Heald D, Ziemniak J, Magner D: Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension. Clin Ther 1992;14:148-157
10. Sista S, Lai JC, Eradiri O, Albert KS: Bioavailability of once-daily dosing of graded-release diltiazem in the morning versus evening. Poster presentation at American College of Clinical Pharmacy Annual Meeting in Albuquerque, New Mexico, 2002
11. Glasser SP, Neutel JM, Gana TJ, Albert KS: Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension. Am J Hypertens 2003;16:51-58
12. Chaffman M, Brogden RN: Diltiazem: A review of its pharmacological properties and therapeutic efficacy. Drugs 1985;29:387-454
13. Chugh SK, Digpal K, Hutchison T, Mcdonald CJ, Miller AJ, Lahiri A: A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina. J Cardiovasc Pharmacol 2001;38:356-364
14. Frishman WH, Charlap S, Goldberger J, Kimmel B, Stroh J, Dorsa F, Allen L, Strom J: Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension. Am J Cardiol 1985;56:41H-46H
15. Klinke WP, Kvill L, Dempsey EE, Grace M: A randomized double-blind comparison of diltiazem and nifedipine in stable angina. J Am Coll Cardiol 1988;12:1562-1567
16. Strauss WE, McIntyre KM, Parisi AF, Shapiro W: Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trial. Am J Cardiol 1982;49:560-566
17. Knight CJ, Fox KM: Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators. Am J Cardiol 1998;81: 133-136
18. Pool PE, Massie BM, Venkataraman K, Hirsch AT, Samant DR, Seagren SC, Gaw J, Salel AF, Tubau JF: Diltiazem as monotherapy for systemic hypertension: A multicenter, randomized, placebo-controlled trial. Am J Cardiol 1986;57:212-217
19. Leenen FH, Fourney A: Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass. Am J Cardiol 1996;78:203-207
20. Schulte KL, Meyer-Sabellek WA, Haertenberger A, Thiede HM, Roecker L, Distler A, Gotzen R: Antihypertensive and metabolic effects of diltiazem and nifedipine. Hypertension 1986;8:859-865
21. Terranova R, Luca S: Treatment of arterial hypertension in the elderly with diltiazem vs. ramipril. Minerva Cardioangiol 2000;48: 183-196
22. Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire L, Dahlof B, Karlberg BE: Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic diltiazem (NORDIL) study. Lancet 2000;356:359-365
23. Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, Siostrzonek P, Heinz G: Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 2001;29:1149-1153
24. Smith NL, Reiber GE, Psaty BM, Heckbert SR, Siscovick DS, Ritchie JL, Every NR, Koepsell TD: Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina. J Am Coll Cardiol 1998;32:1305-1311
25. Gibson RS, Boden WE, Théroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MH, Schlant RC, Kleiger RE, Young PM, Schechtman K, Perryman MB, Roberts R, the Diltiazem Reinfarction Study Group: Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med 1986;315: 423-429
26. Riopelle RJ, McCans JL: A pilot study of the calcium antagonist diltiazem in migraine syndrome prophylaxis (abstr). Can J Neurol Sci 1982;9:269
27. The ALLHAT officers: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc 2002;288(23):2981-2997
28. Rxlist. Diltiazem. Available at: http://www.rxlist.com/cgi/generic/diltiaz_ids.htm. Accessed August 22, 2002
29. CARDIZEM® LA (diltiazem HCl) (package insert). Morrisville, N.C.: Biovail Pharmaceuticals, 2003